Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3edb9aa141cda1fdc8cb548d0c57f59c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C2945-76973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2301-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C2945-76464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2405-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C45-1756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C45-0408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C45-7686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-041 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L1-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08 |
filingDate |
2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b76ae8735107ab96059d12a5e22a02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c19ec88ed18d72fa8d0e11df20493699 |
publicationDate |
2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3969056-A1 |
titleOfInvention |
Anti-adhesive hydrogel composition |
abstract |
A method of reducing or limiting tissue adhesion comprises contacting the tissue with an effective amount of a hydrogel composition comprising: 2% to 6% by weight hyaluronan, and 3% to 18% by weight methylcellulose, wherein the combined total amount of hyaluronan and methylcellulose in the hydrogel is between 8 and 24% by weight; and wherein the ratio of hyaluronan:methylcellulose is between 1:1 and 1:5 w/w. The hydrogel composition and may be used to reduce or limit tissue adhesion that is correlated with surgery, and may be used in surgeries wherein the surgery is performed through a small incision or opening. |
priorityDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |